FLORIS PLUS M – 10 mL (MEDIUM)
Features
Gallery
FLORIS PLUS M – 10 mL (MEDIUM)
Hyaluronic Acid Body Filler for Contouring and Volume Enhancement
Floris Plus M is a 10 mL cross-linked hyaluronic acid body filler developed for non-surgical body contouring and soft-tissue volume enhancement.
Its medium-consistency, monophasic gel formulation is designed to provide smooth handling, controlled delivery, and natural-looking contour enhancement.
Formulated with 24 mg/mL hyaluronic acid and 0.3% lidocaine, Floris Plus M is developed for use by qualified medical professionals.
Key Features
• Hyaluronic Acid Concentration: 24 mg/mL
• BDDE Cross-Linked Hyaluronic Acid
• Medium-Consistency Monophasic Gel
• Contains 0.3% Lidocaine
• 1 × 10 mL Pre-Filled Syringe
• Designed for Smooth and Controlled Injection
• Expected Duration: 8–12 Months (subject to clinical evidence)
Intended Applications
Floris Plus M is developed for body contouring and soft-tissue volume enhancement. Depending on the product’s approved indications, potential applications may include:
• Bikini Area Contouring
• External Genital Area Volume Enhancement
• Buttock Contouring and Volume Enhancement
• Thigh Contouring
• Soft-Tissue Volume Restoration
• Improvement of Body Contour Symmetry
Product Description
Floris Plus M combines cross-linked hyaluronic acid technology with a medium-consistency gel structure designed for body contouring procedures.
Its 24 mg/mL hyaluronic acid formulation is developed to provide cohesive gel characteristics and controlled delivery during treatment.
The 10 mL pre-filled syringe format is intended for aesthetic procedures requiring larger treatment volumes compared with conventional facial fillers.
The formulation also contains 0.3% lidocaine, a local anesthetic included to help reduce injection-related discomfort.
Quality & Manufacturing
• Country of Origin: South Korea
• Cross-Linked Hyaluronic Acid Formulation
• BDDE Cross-Linking Technology
• Sterile, Single-Use Product
• Intended for Administration by Qualified Medical Professionals
Regulatory approvals, certification details, residual BDDE specifications, and approved treatment indications should be stated according to the manufacturer’s official documentation.
